Actively Recruiting
Systemic Treatments for Alopecia Areata Registry
Led by Erasmus Medical Center · Updated on 2024-02-28
10000
Participants Needed
1
Research Sites
3963 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A multicenter prospective registry (STA2R) is conducted to assess systemic treatments for alopecia areata, focusing on effectiveness, safety, and long-term outcomes.
CONDITIONS
Official Title
Systemic Treatments for Alopecia Areata Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with alopecia areata
- Starting or currently using a systemic treatment for alopecia areata
- Provided informed consent for participation in the registry
You will not qualify if you...
- Not sufficiently capable of understanding the Dutch language
- Not willing to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Erasmus University Medical Center
Rotterdam, Netherlands
Actively Recruiting
Research Team
D
DirkJan Hijnen, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here